Modalis Therapeutics Corporation (TYO:4883)

Japan flag Japan · Delayed Price · Currency is JPY
75.00
+1.00 (1.35%)
May 29, 2025, 1:44 PM JST
5.63%
Market Cap 5.55B
Revenue (ttm) n/a
Net Income (ttm) -1.51B
Shares Out 74.94M
EPS (ttm) -27.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 488,400
Average Volume 1,859,110
Open 75.00
Previous Close 74.00
Day's Range 74.00 - 76.00
52-Week Range 66.00 - 203.00
Beta 0.14
RSI 42.90
Earnings Date May 7, 2025

About Modalis Therapeutics

Modalis Therapeutics Corporation engages in the research and development of therapeutics to treat patients with serious genetic disorders. It is developing therapies for genetic diseases using its proprietary CRISPR-GNDM technology that enables to control gene expressions through modulating the switch (epigenetics of a specific locus. The company has a. joint research agreement with JCR Pharmaceuticals Co., Ltd. to evaluate the drug delivery technology of the gene therapy to the central nervous system (CNS) assuming CNS diseases as a target. Th... [Read more]

Sector Healthcare
Founded 2016
Employees 14
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4883
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.